Formulation pH Optimization

Formulation pH optimization establishes appropriate acidity or basicity maximising drug stability and solubility. pH-dependent solubility requires buffering to optimal pH. Ionisable drugs exhibit pKa-dependent solubility. Protein stability varies substantially with pH. Buffering capacity must resist pH drift during shelf-life.

Buffer system selection balances efficacy against compatibility and cost. Regulatory submissions justify pH selections with supporting data. Quality control monitoring confirms pH maintenance throughout shelf-life. Patient administration routes influence acceptable pH ranges. Emerging buffer systems improve formulation properties.